Binding to IMP, inosine monophosphate.

Binding to a purine ribonucleotide, any compound consisting of a purine ribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety.

A process in which a receptor is transported to, or maintained in, a location within a non-motile cilium.

A process in which a protein is transported to, or maintained in, a location within a ciliary membrane.

A process in which a protein is transported to, or maintained in, a location within a non-motile cilium.

The covalent attachment of a mannose residue to a substrate molecule.

Nuclear bodies frequently found near or associated with Cajal bodies (also called coiled bodies or CBs). Gemini of coiled bodies, or 'gems', are similar in size and shape to CBs, and often indistinguishable under the microscope. Unlike CBs, gems do not contain small nuclear ribonucleoproteins (snRNPs); they contain a protein called survivor of motor neurons (SMN) whose function relates to snRNP biogenesis. Gems are believed to assist CBs in snRNP biogenesis, and to play a role in the etiology of spinal muscular atrophy (SMA).

A ubiquitin ligase complex found to be involved in post-replicative bypass of UV-damaged DNA and UV mutagenesis. In S. cerevisiae, the complex contains the ubiquitin conjugating enzyme Rad6 and Rad18, a protein containing a RING finger motif and a nucleotide binding motif. The yeast Rad6-Rad18 heterodimer has ubiquitin conjugating activity, binds single-stranded DNA, and possesses single-stranded DNA-dependent ATPase activity.

DNA N-glycosylase activity acting on deaminated bases.

DNA N-glycosylase activity acting on deaminated adenine (hypoxanthine).

DNA N-glycosylase activity acting on deaminated guanine (xanthine).

DNA N-glycosylase activity acting on deaminated guanine where the resulting base (oxanine) is generated by NO- or HNO2-induced nitrosative deamination.

Any process that modulates the frequency, rate or extent of erythrocyte apoptotic process.

Any process that modulates the frequency, rate, or extent of myeloid cell apoptotic process.

Any process that stops, prevents or reduces the frequency, rate or extent of erythrocyte apoptotic process.

Any process that stops, prevents, or reduces the frequency, rate, or extent of a myeloid cell apoptotic process.

Any process that activates or increases the frequency, rate or extent of erythrocyte apoptotic process.

Any process that activates or increases the frequency, rate, or extent of myeloid cell apoptotic process.

Any process that modulates the frequency, rate or extent of signal transduction by p53 class mediator.

Any process that activates or increases the frequency, rate or extent of bacterial-type flagellum assembly.